Dialysis Equipment-United States Market Status and Trend Report 2013-2023
![](/report_cover/10724/dialysis-equipment-united-states-market-status-n-trend-report-2013-2023_en.gif)
Report Summary
Dialysis Equipment-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Dialysis Equipment industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Dialysis Equipment 2013-2017, and development forecast 2018-2023
Main market players of Dialysis Equipment in United States, with company and product introduction, position in the Dialysis Equipment market
Market status and development trend of Dialysis Equipment by types and applications
Cost and profit status of Dialysis Equipment, and marketing status
Market growth drivers and challenges
The report segments the United States Dialysis Equipment market as:
United States Dialysis Equipment Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Dialysis Equipment Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Monitoring Equipment
Dialysis Solution Supply Equipment
United States Dialysis Equipment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Dialysis Centers
Hospitals
Home Care Settings
Research Laboratories
United States Dialysis Equipment Market: Players Segment Analysis (Company and Product introduction, Dialysis Equipment Sales Volume, Revenue, Price and Gross Margin):
NxStage
Aksys Ltd
Diaverum
Texas Instruments
Teleflex Medical
Asahi Kasei Medical
B. Braun Melsungen AG
Nipro Medical Corporation
Sorin Group
Gambro AB
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Dialysis Equipment-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Dialysis Equipment industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Dialysis Equipment 2013-2017, and development forecast 2018-2023
Main market players of Dialysis Equipment in United States, with company and product introduction, position in the Dialysis Equipment market
Market status and development trend of Dialysis Equipment by types and applications
Cost and profit status of Dialysis Equipment, and marketing status
Market growth drivers and challenges
The report segments the United States Dialysis Equipment market as:
United States Dialysis Equipment Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Dialysis Equipment Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Monitoring Equipment
Dialysis Solution Supply Equipment
United States Dialysis Equipment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Dialysis Centers
Hospitals
Home Care Settings
Research Laboratories
United States Dialysis Equipment Market: Players Segment Analysis (Company and Product introduction, Dialysis Equipment Sales Volume, Revenue, Price and Gross Margin):
NxStage
Aksys Ltd
Diaverum
Texas Instruments
Teleflex Medical
Asahi Kasei Medical
B. Braun Melsungen AG
Nipro Medical Corporation
Sorin Group
Gambro AB
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEXT GENERATION SEQUENCING
1.1 Definition of Next Generation Sequencing in This Report
1.2 Commercial Types of Next Generation Sequencing
1.2.1 454-Sequencing
1.2.2 Illumina Sequencing
1.2.3 Others
1.3 Downstream Application of Next Generation Sequencing
1.3.1 Oncology
1.3.2 Hereditary Disease Detection
1.3.3 Life Science
1.4 Development History of Next Generation Sequencing
1.5 Market Status and Trend of Next Generation Sequencing 2013-2023
1.5.1 Global Next Generation Sequencing Market Status and Trend 2013-2023
1.5.2 Regional Next Generation Sequencing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Next Generation Sequencing 2013-2017
2.2 Production Market of Next Generation Sequencing by Regions
2.2.1 Production Volume of Next Generation Sequencing by Regions
2.2.2 Production Value of Next Generation Sequencing by Regions
2.3 Demand Market of Next Generation Sequencing by Regions
2.4 Production and Demand Status of Next Generation Sequencing by Regions
2.4.1 Production and Demand Status of Next Generation Sequencing by Regions 2013-2017
2.4.2 Import and Export Status of Next Generation Sequencing by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Next Generation Sequencing by Types
3.2 Production Value of Next Generation Sequencing by Types
3.3 Market Forecast of Next Generation Sequencing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencing by Downstream Industry
4.2 Market Forecast of Next Generation Sequencing by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCING
5.1 Global Economy Situation and Trend Overview
5.2 Next Generation Sequencing Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Next Generation Sequencing by Major Manufacturers
6.2 Production Value of Next Generation Sequencing by Major Manufacturers
6.3 Basic Information of Next Generation Sequencing by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Next Generation Sequencing Major Manufacturer
6.3.2 Employees and Revenue Level of Next Generation Sequencing Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher Scientific
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencing Product
7.1.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencing Product
7.2.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Roche Sequencing
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencing Product
7.3.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche Sequencing
7.4 Pacific Biosciences
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencing Product
7.4.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Pacific Biosciences
7.5 BGI
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencing Product
7.5.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of BGI
7.6 Novo gene
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencing Product
7.6.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Novo gene
7.7 Biomarker
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencing Product
7.7.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Biomarker
7.8 Roche
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencing Product
7.8.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche
7.9 Daan Gene
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencing Product
7.9.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Daan Gene
7.10 Berry Genomics
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencing Product
7.10.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Berry Genomics
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCING
8.1 Industry Chain of Next Generation Sequencing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCING
9.1 Cost Structure Analysis of Next Generation Sequencing
9.2 Raw Materials Cost Analysis of Next Generation Sequencing
9.3 Labor Cost Analysis of Next Generation Sequencing
9.4 Manufacturing Expenses Analysis of Next Generation Sequencing
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Next Generation Sequencing in This Report
1.2 Commercial Types of Next Generation Sequencing
1.2.1 454-Sequencing
1.2.2 Illumina Sequencing
1.2.3 Others
1.3 Downstream Application of Next Generation Sequencing
1.3.1 Oncology
1.3.2 Hereditary Disease Detection
1.3.3 Life Science
1.4 Development History of Next Generation Sequencing
1.5 Market Status and Trend of Next Generation Sequencing 2013-2023
1.5.1 Global Next Generation Sequencing Market Status and Trend 2013-2023
1.5.2 Regional Next Generation Sequencing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Next Generation Sequencing 2013-2017
2.2 Production Market of Next Generation Sequencing by Regions
2.2.1 Production Volume of Next Generation Sequencing by Regions
2.2.2 Production Value of Next Generation Sequencing by Regions
2.3 Demand Market of Next Generation Sequencing by Regions
2.4 Production and Demand Status of Next Generation Sequencing by Regions
2.4.1 Production and Demand Status of Next Generation Sequencing by Regions 2013-2017
2.4.2 Import and Export Status of Next Generation Sequencing by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Next Generation Sequencing by Types
3.2 Production Value of Next Generation Sequencing by Types
3.3 Market Forecast of Next Generation Sequencing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencing by Downstream Industry
4.2 Market Forecast of Next Generation Sequencing by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCING
5.1 Global Economy Situation and Trend Overview
5.2 Next Generation Sequencing Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Next Generation Sequencing by Major Manufacturers
6.2 Production Value of Next Generation Sequencing by Major Manufacturers
6.3 Basic Information of Next Generation Sequencing by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Next Generation Sequencing Major Manufacturer
6.3.2 Employees and Revenue Level of Next Generation Sequencing Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher Scientific
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencing Product
7.1.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencing Product
7.2.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Roche Sequencing
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencing Product
7.3.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche Sequencing
7.4 Pacific Biosciences
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencing Product
7.4.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Pacific Biosciences
7.5 BGI
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencing Product
7.5.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of BGI
7.6 Novo gene
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencing Product
7.6.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Novo gene
7.7 Biomarker
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencing Product
7.7.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Biomarker
7.8 Roche
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencing Product
7.8.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche
7.9 Daan Gene
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencing Product
7.9.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Daan Gene
7.10 Berry Genomics
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencing Product
7.10.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Berry Genomics
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCING
8.1 Industry Chain of Next Generation Sequencing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCING
9.1 Cost Structure Analysis of Next Generation Sequencing
9.2 Raw Materials Cost Analysis of Next Generation Sequencing
9.3 Labor Cost Analysis of Next Generation Sequencing
9.4 Manufacturing Expenses Analysis of Next Generation Sequencing
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference